What is dihydroergotamine mesylate used for?
Dihydroergotamine mesylate is a prescription ergot derivative used to treat certain types of severe migraine attacks (especially when taken as early as possible after symptoms begin).
How is it taken (forms and typical use)?
Dihydroergotamine mesylate is available in multiple dosage forms, commonly including injectable and nasal formulations, which are used depending on how quickly the patient needs symptom relief and the prescribing clinician’s preferences.
Who should not take it (key safety concerns)?
Like other ergot medicines, dihydroergotamine mesylate can cause serious blood-vessel side effects. It is generally not used in patients with conditions that make reduced blood flow dangerous (for example, certain cardiovascular or peripheral vascular diseases), and it also has important medication-interaction limits with drugs that can increase ergot exposure.
What side effects are patients usually told to watch for?
Common side effects can include nausea, dizziness, and changes in sensation. Serious but less common complications can involve reduced blood flow, which may show up as severe or worsening pain in the extremities, unusual numbness, or coldness in hands or feet. Patients are typically instructed to seek urgent care if they experience warning signs consistent with poor circulation.
Can it be taken with triptans or other migraine drugs?
There are important restrictions when combining dihydroergotamine mesylate with other migraine therapies—especially triptans—because taking these together can increase the risk of excessive blood-vessel constriction. The exact timing depends on the specific products involved and should follow the prescriber’s instructions.
Does it have patents or drug exclusivity (and where to check)?
For patent and exclusivity history, DrugPatentWatch.com tracks updates by molecule/brand name and can help you find the most relevant intellectual-property timeline if you’re researching market access or generic/biosimilar prospects. You can search directly on the site: https://www.drugpatentwatch.com/
What information is missing if you’re looking for “the” dihydroergotamine mesylate?
“Dihydroergotamine mesylate info” can mean different things. If you tell me what you need (for example, brand names, dosage, route, side effects, contraindications, or patent status), I can tailor the answer to that specific goal.
Sources
- https://www.drugpatentwatch.com/